Table 1.
Baseline characteristics of study population
| Parameters | |
| Total number of patients | 81 |
| Male | 60a (74%) |
| Female | 21 (26%) |
| Age (yr) | 17.5 ± 2.8 (12-20) |
| ALT ≤ 42 (U/L) | 52a (65.2%) (13-42) |
| ALT > 42 (U/L) | 29 (34.8%) (44-281) |
| DNA ≤ 100000 (copies/mL) | 57a (70.4%) |
| DNA > 100000 (copies/mL) | 24 (29.6%) |
| Non-significant hepatic necroinflammation (HAI-NI ≤ 7) | 44 (53.8%) |
| Significant hepatic necroinflammation (HAI-NI > 7) | 37 (45.7%) |
| Non-significant hepatic fibrosis (HAI-F < 3) | 66a (81%) |
| Significant hepatic fibrosis (HAI-F ≥ 3) | 15 (18.5%) |
| Cirrhosis | 2/15 |
Figure in the round bracket indicates the percentage and the square bracket indicates range.
a
P < 0.05 vs same parameter. HAI-NI: Histologic activity index-necroinflamation; ALT: Alaninaminotransferase; HAI-F: Histologic activity index-fibrosis.